U.S. Markets closed

Pharmstandard International S.A. Buys Allena Pharmaceuticals Inc

- By insider

Investment company Pharmstandard International S.A. buys Allena Pharmaceuticals Inc during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Pharmstandard International S.A.. As of 2017-12-31, Pharmstandard International S.A. owns 4 stocks with a total value of $42 million. These are the details of the buys and sells.

  • New Purchases: ALNA,


For the details of Pharmstandard International S.A.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Pharmstandard+International+S.A.

These are the top 5 holdings of Pharmstandard International S.A.

  1. Protagonist Therapeutics Inc (PTGX) - 982,270 shares, 48.1% of the total portfolio.
  2. Allena Pharmaceuticals Inc (ALNA) - 1,037,267 shares, 24.57% of the total portfolio. New Position
  3. Jounce Therapeutics Inc (JNCE) - 662,063 shares, 19.87% of the total portfolio.
  4. Proteon Therapeutics Inc (PRTO) - 1,667,907 shares, 7.46% of the total portfolio.
  5. Argos Therapeutics Inc (ARGS) - 0 shares, 0% of the total portfolio. Shares reduced by 10000%

New Purchase: Allena Pharmaceuticals Inc (ALNA)

Pharmstandard International S.A. initiated holdings in Allena Pharmaceuticals Inc. The purchase prices were between $9.79 and $14.89, with an estimated average price of $12.29. The stock is now traded at around $6.38. The impact to the portfolio due to this purchase was 24.57%. The holdings were 1,037,267 shares as of 2017-12-31.



Here is the complete portfolio of Pharmstandard International S.A.. Also check out:


1. Pharmstandard International S.A.'s Undervalued Stocks

2. Pharmstandard International S.A.'s Top Growth Companies, and

3. Pharmstandard International S.A.'s High Yield stocks

4. Stocks that Pharmstandard International S.A. keeps buyingThis article first appeared on GuruFocus.